Literature DB >> 26764000

Mononucleated Blood Cell Populations Display Different Abilities To Transmit Prion Disease by the Transfusion Route.

Jean-Yves Douet1, Caroline Lacroux1, Claire Litaise1, Séverine Lugan1, Fabien Corbière1, Mark Arnold2, Hugh Simmons2, Naima Aron1, Pierrette Costes1, Cécile Tillier1, Hervé Cassard1, Olivier Andréoletti3.   

Abstract

UNLABELLED: Previous experiments carried out in a sheep scrapie model demonstrated that the transfusion of 200 μl of prion-infected whole blood has an apparent 100% efficacy for disease transmission. These experiments also indicated that, despite the apparent low infectious titer, the intravenous administration of white blood cells (WBC) resulted in efficient disease transmission. In the study presented here, using the same transmissible spongiform encephalopathy (TSE) animal model, our aim was to determine the minimal number of white blood cells and the specific abilities of mononucleated cell populations to transmit scrapie by the transfusion route. Our results confirmed that the transfusion of 100 μl, but not 10 μl, of fresh whole blood collected in asymptomatic scrapie-infected donor sheep can transmit the disease. The data also show that the intravenous administration of 10(5) WBCs is sufficient to cause scrapie in recipient sheep. Cell-sorted CD45R(+) (predominantly B lymphocytes), CD4(+)/CD8(+) (T lymphocytes), and CD14(+) (monocytes/macrophages) blood cell subpopulations all were shown to contain prion infectivity by bioassays in ovine PrP transgenic mice. However, while the intravenous administration of 10(6) CD45(+) or CD4(+)/8(+) living cells was able to transmit the disease, similar numbers of CD14(+) cells failed to infect the recipients. These data support the contention that mononucleated blood cell populations display different abilities to transmit TSE by the transfusion route. They also represent an important input for the risk assessment of blood-borne prion disease transmission and for refining the target performance of leukoreduction processes that currently are applied to mitigate the transmission risk in transfusion medicine. IMPORTANCE: Interindividual variant Creutzfeldt-Jakob disease (vCJD) transmission through blood and blood-derived products is considered a major public health issue in transfusion medicine. Over the last decade, TSE in sheep has emerged as a relevant model for assessing the blood-borne vCJD transmission risk. In this study, using a sheep TSE model, we characterized the ability of different peripheral blood mononucleated cell populations to infect TSE-free recipients by the transfusion route. Our results indicate that as little as 10(5) WBC and 100 μl of blood collected from asymptomatic scrapie infected animals can transmit the disease. They also demonstrate unambiguously that peripheral blood mononuclear cell subpopulations display dramatically different abilities to transmit the disease. These data represent an important input for the risk assessment of blood-borne prion disease transmission and for refining the target performance of leukoreduction processes that currently are applied to mitigate the transmission risk in transfusion medicine.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26764000      PMCID: PMC4794699          DOI: 10.1128/JVI.02783-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models.

Authors:  Caroline Lacroux; Didier Vilette; Natalia Fernández-Borges; Claire Litaise; Séverine Lugan; Nathalie Morel; Fabien Corbière; Stéphanie Simon; Hugh Simmons; Pierrette Costes; Jean-Louis Weisbecker; Isabelle Lantier; Frederic Lantier; François Schelcher; Jacques Grassi; Joaquin Castilla; Olivier Andréoletti
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 2.  Leukoreduction and blood-borne vCJD transmission risk.

Authors:  Jean Yves Douet; Raymond Bujdoso; Olivier Andréoletti
Journal:  Curr Opin Hematol       Date:  2015-01       Impact factor: 3.284

Review 3.  From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.

Authors:  Jean-Jacques Lefrère; Patricia Hewitt
Journal:  Transfusion       Date:  2009-01-02       Impact factor: 3.157

4.  PrP expression level and sensitivity to prion infection.

Authors:  Jean-Yves Douet; Caroline Lacroux; Fabien Corbière; Claire Litaise; Hugh Simmons; Séverine Lugan; Pierrette Costes; Hervé Cassard; Jean-Louis Weisbecker; François Schelcher; Olivier Andreoletti
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

5.  Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.

Authors:  A Peden; L McCardle; M W Head; S Love; H J T Ward; S N Cousens; D M Keeling; C M Millar; F G H Hill; J W Ironside
Journal:  Haemophilia       Date:  2010-01-12       Impact factor: 4.287

Review 6.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

7.  All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD.

Authors:  Sandra McCutcheon; Anthony Richard Alejo Blanco; E Fiona Houston; Christopher de Wolf; Boon Chin Tan; Antony Smith; Martin H Groschup; Nora Hunter; Valerie S Hornsey; Ian R MacGregor; Christopher V Prowse; Marc Turner; Jean C Manson
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

8.  Highly efficient prion transmission by blood transfusion.

Authors:  Olivier Andréoletti; Claire Litaise; Hugh Simmons; Fabien Corbière; Séverine Lugan; Pierrette Costes; François Schelcher; Didier Vilette; Jacques Grassi; Caroline Lacroux
Journal:  PLoS Pathog       Date:  2012-06-21       Impact factor: 6.823

9.  Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission.

Authors:  Caroline Lacroux; Daisy Bougard; Claire Litaise; Hugh Simmons; Fabien Corbiere; Dominique Dernis; René Tardivel; Nathalie Morel; Stephanie Simon; Séverine Lugan; Pierrette Costes; Jean Louis Weisbecker; François Schelcher; Jacques Grassi; Joliette Coste; Olivier Andréoletti
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease.

Authors:  Jean Yves Douet; Saima Zafar; Armand Perret-Liaudet; Caroline Lacroux; Séverine Lugan; Naima Aron; Herve Cassard; Claudia Ponto; Fabien Corbière; Juan Maria Torres; Inga Zerr; Olivier Andreoletti
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

View more
  6 in total

1.  Problems with precaution: the transfusion medicine experience.

Authors:  Kumanan Wilson; Katherine M Atkinson; Dean A Fergusson; Adalsteinn Brown; Alan Forster; Malia S Q Murphy; Alan T Tinmouth; Jennifer Keelan
Journal:  J Risk Res       Date:  2017-07-29

Review 2.  How do PrPSc Prions Spread between Host Species, and within Hosts?

Authors:  Neil A Mabbott
Journal:  Pathogens       Date:  2017-11-24

3.  Preclinical transmission of prions by blood transfusion is influenced by donor genotype and route of infection.

Authors:  M Khalid F Salamat; A Richard Alejo Blanco; Sandra McCutcheon; Kyle B C Tan; Paula Stewart; Helen Brown; Allister Smith; Christopher de Wolf; Martin H Groschup; Dietmar Becher; Olivier Andréoletti; Marc Turner; Jean C Manson; E Fiona Houston
Journal:  PLoS Pathog       Date:  2021-02-18       Impact factor: 6.823

4.  Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients.

Authors:  Jean-Yves Douet; Alvina Huor; Hervé Cassard; Séverine Lugan; Naima Aron; Mark Arnold; Didier Vilette; Juan-Maria Torres; James W Ironside; Olivier Andreoletti
Journal:  Acta Neuropathol       Date:  2021-02-02       Impact factor: 17.088

5.  Reduced Expression of Prion Protein With Increased Interferon-β Fail to Limit Creutzfeldt-Jakob Disease Agent Replication in Differentiating Neuronal Cells.

Authors:  Gerard Aguilar; Nathan Pagano; Laura Manuelidis
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

6.  Experimental inoculation of CD11c+ B1 lymphocytes, CD68+ macrophages, or platelet-rich plasma from scrapie-infected sheep into susceptible sheep results in variable infectivity.

Authors:  Najiba Mammadova; Eric D Cassmann; S Jo Moore; Eric M Nicholson; Justin J Greenlee
Journal:  Access Microbiol       Date:  2020-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.